Table 2.
Age-adjusted UBC incidence rates per 100,000 person-years for the whole cohort and different racial groups, stratified by gender, age and histological type.
| Total | NHW | HW | Black | API | |
|---|---|---|---|---|---|
| All ages | 19.53 (19.44–19.62) | 23.09 (22.97–23.21) | 11.10 (10.86–11.34) | 12.60 (12.33–12.87) | 9.51 (9.31–9.71) |
| 0–39 | 0.43 (0.41–0.44) | 0.57 (0.55–0.60) | 0.25 (0.22–0.28) | 0.27 (0.23–0.31) | 0.18 (0.15–0.22) |
| 40–64 | 15.36 (15.22–15.50) | 19.11 (18.92–19.31) | 7.87 (7.59–8.17) | 10.22 (9.85–10.59) | 6.48 (6.21–6.75) |
| 65–84 | 110.28 (109.60–110.97) | 129.22 (128.34–130.10) | 62.72 (60.97–64.52) | 69.70 (67.74–71.70) | 53.64 (52.19–55.12) |
| ≥85 | 154.23 (152.15–156.34) | 169.34 (166.86–171.85) | 103.75 (97.18–110.66) | 104.18 (97.49–111.20) | 95.93 (90.51–101.59) |
| Gender | |||||
| Male | 34.46 (34.26–34.65) | 40.58 (40.33–40.83) | 19.41 (18.90–19.92) | 20.78 (20.22–21.35) | 16.57 (16.16–16.98) |
| Female | 8.62 (8.53–8.70) | 10.00 (9.90–10.11) | 5.25 (5.03–5.46) | 7.25 (6.99–7.52) | 4.24 (4.06–4.42) |
| Histological types | |||||
| PTCC | 13.37 (13.29–13.45) | 16.14 (16.04–16.24) | 7.08 (6.89–7.27) | 7.23 (7.03–7.44) | 6.06 (5.90–6.22) |
| NPTCC | 4.91 (4.86–4.96) | 5.59 (5.53–5.65) | 3.07 (2.95–3.20) | 3.97 (3.82–4.12) | 2.82 (2.71–2.93) |
| CARCINOMA | 0.23 (0.22–0.24) | 0.32 (0.31–0.34) | 0.21 (0.18–0.24) | 0.32 (0.28–0.36) | 0.17 (0.14–0.20) |
| SCC | 0.30 (0.28–0.31) | 0.25 (0.24–0.26) | 0.19 (0.16–0.22) | 0.33 (0.29–0.38) | 0.07 (0.06–0.09) |
Diagnoses in the period of 1992–2014 in the SEER 13 database. In each cell, estimated rate (95% confidence interval). Rates were age-adjusted using the U.S. 2000 Census population.